Versatope Therapeutics

company

About

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.

  • Lowell,Massachusetts,United States
  • 1 - 10

Details

Last Funding Type
Funding Round
Last Funding Money Raised
$193K
Industries
Biotechnology
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$18.39M
Versatope Therapeutics has raised a total of $18.39M in funding over 2 rounds. Their latest funding was raised on Sep 9, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 9, 2020 Grant $300K 1 Detail
Sep 3, 2019 Funding Round $193K Detail
Sep 26, 2018 Grant $17.90M 1 Detail
May 23, 2017 Non-Equity Assistant 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Versatope Therapeutics is funded by 3 investors. Massachusetts Life Sciences Center and National Institute of Allergy and Infectious Diseases are the most recent investors.
Investor Name Lead Investor Funding Round
Massachusetts Life Sciences Center Grant
National Institute of Allergy and Infectious Diseases Grant
MassChallenge Non-Equity Assistant

Employee Profiles

Number of Employee Profiles
1
Versatope Therapeutics has 1 current employee profiles, including Executive Christopher Locher
Executive